{"id":97558,"date":"2019-10-17T21:23:31","date_gmt":"2019-10-18T04:23:31","guid":{"rendered":"https:\/\/lifeboat.com\/blog\/2019\/10\/the-top-10-companies-working-to-increase-longevity"},"modified":"2019-10-17T21:23:31","modified_gmt":"2019-10-18T04:23:31","slug":"the-top-10-companies-working-to-increase-longevity","status":"publish","type":"post","link":"https:\/\/lifeboat.com\/blog\/2019\/10\/the-top-10-companies-working-to-increase-longevity","title":{"rendered":"The Top 10 Companies Working to Increase Longevity"},"content":{"rendered":"<p><a class=\"aligncenter blog-photo\" href=\"https:\/\/lifeboat.com\/blog.images\/the-top-10-companies-working-to-increase-longevity.jpg\"><\/a><\/p>\n<p>The core of what we do at Nanalyze is to tell our readers all they need to know about investing in emerging technologies. Sometimes that story is much, much bigger, and what we\u2019re really talking about is investing in emerging industries. NewSpace is one example, launching about 15 years ago with the emergence of companies like SpaceX and Virgin Galactic. It\u2019s probably only within the last five years that the NewSpace industry has achieved real liftoff, with dozens of startups doing everything from offering <a href=\"https:\/\/www.nanalyze.com\/2018\/11\/rocket-lab-newspace\/\" target=\"_blank\" rel=\"noopener noreferrer\">launch services<\/a> to <a href=\"https:\/\/www.nanalyze.com\/2019\/03\/smallsat-companies-building-launching-satellites\/\" target=\"_blank\" rel=\"noopener noreferrer\">building satellites<\/a> to developing <a href=\"https:\/\/www.nanalyze.com\/2019\/07\/satellite-imagery-data-generate-alpha\/\" target=\"_blank\" rel=\"noopener noreferrer\">business analytics from space-based imagery<\/a>. While we may one day end up living on Mars, we\u2019re more interested in living a long and fruitful life right here on Mother Earth, despite the specter of <a href=\"https:\/\/www.nanalyze.com\/2017\/12\/introduction-cancer-immunotherapy-treatments\/\" target=\"_blank\" rel=\"noopener noreferrer\">cancer<\/a> and <a href=\"https:\/\/www.nanalyze.com\/2018\/09\/startups-cure-alzheimers\/\" target=\"_blank\" rel=\"noopener noreferrer\">dementia<\/a>. An entire industry is coalescing around human longevity, promising to beat these age-related diseases and extend our lives to biblical proportions.<\/p>\n<p>We\u2019ve been covering the topic of <a href=\"https:\/\/www.nanalyze.com\/tag\/life-extension-science\/\" target=\"_blank\" rel=\"noopener noreferrer\">life extension<\/a> for more than five years, beginning with a profile on an anti-aging company called <a href=\"https:\/\/www.nanalyze.com\/2014\/03\/live-longer-with-human-longevity\/\" target=\"_blank\" rel=\"noopener noreferrer\">Human Longevity Inc<\/a>, whose founders include billionaire serial entrepreneur <a href=\"https:\/\/www.diamandis.com\/about\" target=\"_blank\" rel=\"noopener noreferrer\">Peter Diamandis<\/a> and <a href=\"https:\/\/www.jcvi.org\/about\/jcventer\" target=\"_blank\" rel=\"noopener noreferrer\">J. Craig Venter<\/a>, a leading genomics expert. More recently, we introduced you to nine companies developing products in <a href=\"https:\/\/www.nanalyze.com\/2019\/02\/regenerative-medicine-companies\/\" target=\"_blank\" rel=\"noopener noreferrer\">regenerative medicine<\/a>, a broad category that refers to restoring the structure and function of damaged tissues or organs. We also tackled the more controversial topic of <a href=\"https:\/\/www.nanalyze.com\/2019\/06\/young-blood-transfusions\/\" target=\"_blank\" rel=\"noopener noreferrer\">young blood transfusions<\/a> earlier this year, as well as covered the <a href=\"https:\/\/www.nanalyze.com\/2019\/03\/precision-biosciences-stock\/\" target=\"_blank\" rel=\"noopener noreferrer\">2019 IPO of Precision BioSciences<\/a> (<a href=\"https:\/\/www.bloomberg.com\/quote\/DTIL: US\" target=\"_blank\" rel=\"noopener noreferrer\">DTIL<\/a>), a <a href=\"https:\/\/www.nanalyze.com\/2018\/03\/updates-progress-gene-editing\/\" target=\"_blank\" rel=\"noopener noreferrer\">gene-editing<\/a> company that wants to fight disease and re-engineer food.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>The core of what we do at Nanalyze is to tell our readers all they need to know about investing in emerging technologies. Sometimes that story is much, much bigger, and what we\u2019re really talking about is investing in emerging industries. NewSpace is one example, launching about 15 years ago with the emergence of companies [\u2026]<\/p>\n","protected":false},"author":511,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[11,43,1506,412,269,47,2020,2028],"tags":[],"class_list":["post-97558","post","type-post","status-publish","format-standard","hentry","category-biotech-medical","category-business","category-food","category-genetics","category-life-extension","category-neuroscience","category-peter-diamandis","category-satellites"],"_links":{"self":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/97558","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/users\/511"}],"replies":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/comments?post=97558"}],"version-history":[{"count":0,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/97558\/revisions"}],"wp:attachment":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/media?parent=97558"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/categories?post=97558"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/tags?post=97558"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}